Clinical Trials Browser

Phase 1/2 × Advanced Lung Cancer × toripalimab × Clear all

NCT05664971 2025-12-02

JS004 Combined With Toripalimab and With Standard Chemotherapy Treat Patients With Advanced Lung Cancer

Phase 1/2 Completed

Advanced Lung Cancer

NCT05000684 2025-02-20

Study of JS004 Combined With Toripalimab for Advanced Lung Cancer

Phase 1/2 Completed

Advanced Lung Cancer